Previous Article | Next Article ![]()
J. Virol., 05 1995, 2776-2785, Vol 69, No. 5
DR Milich, DL Peterson, F Schodel, JE Jones and JL Hughes
Regulatory T-helper (Th) cells have been categorized into two functional
subsets, Th1 and Th2 cells, which produce distinct lymphokines. In general,
Th1 cells mediate cellular immune responses and Th2 cells mediate humoral
immunity. Recent serological studies suggest that the Th1-Th2 balance may
be relevant in acute and chronic hepatitis B virus (HBV) infections. The
purpose of this study was to determine the potential of the nucleocapsid
antigens (Ags) (hepatitis B core and e Ags [HBc/eAg]) of HBV to
preferentially elicit either a Th1 or a Th2 dominant response. For this
purpose, H-2 congenic B10.S and B10 mice were immunized with HBc/eAg, and
Ag-specific T-cell proliferative responses, T-cell helper function, and
T-cell cytokine production were analyzed. The results indicated that B10.S
mice preferentially develop a Th1-like response whereas B10 mice
preferentially develop a Th2-like response after immunization with HBc/eAg.
Furthermore, the preferential Th1 and Th2 response patterns were reproduced
when 12-residue peptides representing the dominant HBc/eAg-specific T-cell
sites for B10.S (peptide 120-131) and B10 (peptide 129-140) mice were used
as immunogens. Therefore, the combination of the T-cell site recognized and
the major histocompatibility complex restricting element can in large part
determine the Th phenotype of the HBc/eAg-specific T-cell response. Other
factors that influenced Th phenotype were the presence of exogenous
cytokines, Ag structure, and tissue distribution.
Copyright © 1995, American Society for Microbiology
Preferential recognition of hepatitis B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent
Department of Molecular Biology, Scripps Research Institute, La Jolla, California 92037, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|